Industry

National Institute for Health Research (NIHR) BioResource is a unique collaboration bringing people, facilities and research excellence together to create a valuable resource for your clinical trials.

Successful clinical trials require quick, reliable and accurate data, data which will allow you as researchers to make decisions on whether or not to continue with a novel treatment or device trial.

BioResource makes available to researchers well characterised groups of individuals by genotype and or phenotype, who have agreed to participate in clinical trials.

By establishing this resource the NIHR hope to foster strong collaborations between industry, the NHS and academia. Not only will your company benefit through access to individuals tailored for your trials, but will also receive advice, support and feedback from key opinion leaders, the clinicians and academics working in your field of research.

“We have had a very productive relationship with Cambridge BioResource (CBR) over the last 2-3 years where collaboration has resulted is provision of genetic resource, conduct of clinical and translational trials, and publication of both clinical and immuno-inflammatory mechanistic study results related to pharmacogenetic interactions. The initial interactions between us and CBR have been very successful and this is a collaboration we are keen to maintain and develop.”

GlaxoSmithKline

All applications to use the BioResource are reviewed by the Steering Committee/ Scientific Advisory Board.
For more details on how to apply please email nbr